dual norepinephrine reuptake inhibitors/5-HT1A partial agonists (Pfizer)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namedual norepinephrine reuptake inhibitors/5-HT1A partial agonists (Pfizer)
Drug Alias NamePF-04269339PF-03529936
ClassificationSmall molecules
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor partial agonistsNorepinephrine reuptake inhibitors
TargetsNorepinephrine transporterSerotonin 1a (5-HT1a) receptor
Therapy Area/IndicationsMental Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Global Research and Development
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Global Research and Development
Active IndicationsN/A
Inactive IndicationsMental Disorders

Other Information

ATC CodeN/A
Related LinksN/A